Accuray's (ARAY) gross orders were driven by solid EMEA momentum in Q3.
Investor confidence remains high in Accuray (ARAY) stock, thanks to solid prospects.
Shareholders will be ecstatic, with their stake up 24% over the past week following Accuray Incorporated's...
The availability of NextGen's (NXGN) Patient Experience Platform is likely to enable high-quality healthcare and drive patient engagement.
Accuray (ARAY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Accuray (ARAY) delivered earnings and revenue surprises of 200.00% and 3.21%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Since the coronavirus outbreak, robots have filled up several job vacancies caused by social distancing orders. Here are five robotics and related stocks investors should closely watch.
Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Welcome to Accuray's conference call to review financial results for the third quarter of fiscal year 2020, which ended March 31, 2020. Joining us today are Josh Levine, Accuray's President and Chief Executive Officer; and Shig Hamamatsu, Accuray's Senior Vice President and Chief Financial Officer.
Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2020 on Tuesday, April 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.
Accuray (ARAY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Joshua Levine has been the CEO of Accuray Incorporated (NASDAQ:ARAY) since 2012. This report will, first, examine the...
Baxter (BAX) issues strong guidance for the first quarter of 2020.
PerkinElmer (PKI) expects to witness foreign exchange headwinds in 2020.
Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2020 ended March 31, 2020.
Q3 2020 Accuray Inc Earnings Call
DaVita (DVA) continues to gain traction from strong international foothold, strategic buyout of dialysis centers and DaVita Kidney Care.
Accuray Incorporated (NASDAQ: ARAY) today announced that MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, has selected the Accuray Synchrony® Real-time Adaptive Technology for the Radixact® System as the winner of its "Best Overall Medical Device Solution" award in the fourth annual MedTech Breakthrough Awards program.
Accuray has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
HealthEquity's (HQY) fiscal fourth-quarter earnings benefit from higher revenues and solid performing Service, Custodial and Interchange segments.